These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
810 related items for PubMed ID: 24878287
21. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Mu N, Gu J, Liu N, Xue X, Shu Z, Zhang K, Huang T, Chu C, Zhang W, Gong L, Zhao H, Jia B, Gao D, Shang L, Zhang W, Guo Q. Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339 [Abstract] [Full Text] [Related]
22. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Marucci G, Morandi L, Magrini E, Farnedi A, Franceschi E, Miglio R, Calò D, Pession A, Foschini MP, Eusebi V. Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566 [Abstract] [Full Text] [Related]
23. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB. Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492 [Abstract] [Full Text] [Related]
24. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival. Yoshida Y, Nakada M, Sugimoto N, Harada T, Hayashi Y, Kita D, Uchiyama N, Hayashi Y, Yachie A, Takuwa Y, Hamada J. Int J Cancer; 2010 May 15; 126(10):2341-52. PubMed ID: 19810093 [Abstract] [Full Text] [Related]
25. Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma. Chen CH, Chen PY, Lin YY, Feng LY, Chen SH, Chen CY, Huang YC, Huang CY, Jung SM, Chen LY, Wei KC. J Neurosurg; 2020 Jan 01; 132(1):168-179. PubMed ID: 30641835 [Abstract] [Full Text] [Related]
26. Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas. Wang H, Li P, Zhao B. Gene; 2013 Oct 10; 528(2):146-53. PubMed ID: 23911301 [Abstract] [Full Text] [Related]
27. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines. Li YF, Tsai WC, Chou CH, Huang LC, Huang SM, Hueng DY, Tsai CK. Int J Mol Sci; 2020 Dec 27; 22(1):. PubMed ID: 33375517 [Abstract] [Full Text] [Related]
28. Insulin-like growth factor binding protein-2 and glucose-regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH-wildtype glioblastoma patients. Harland AJ, Perks CM, White P, Kurian KM, Barber HR. Cancer Med; 2023 Jul 27; 12(13):14426-14439. PubMed ID: 37212470 [Abstract] [Full Text] [Related]
29. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma. Meng D, Chen Y, Yun D, Zhao Y, Wang J, Xu T, Li X, Wang Y, Yuan L, Sun R, Song X, Huai C, Hu L, Yang S, Min T, Chen J, Chen H, Lu D. Oncotarget; 2015 Mar 10; 6(7):4901-19. PubMed ID: 25669971 [Abstract] [Full Text] [Related]
30. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T, Takeshima H, Yamashita S, Mizuguchi S, Fukushima T, Yokogami K, Yamasaki K. J Neurosurg; 2015 Feb 10; 122(2):317-23. PubMed ID: 25415071 [Abstract] [Full Text] [Related]
31. Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion. Li M, Li X, Xu S, Xue P, Li Q, Lu Q, Jia Q, Zhang L, Li X, Li X. Tumour Biol; 2016 Sep 10; 37(9):11893-11901. PubMed ID: 27059736 [Abstract] [Full Text] [Related]
32. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y, Wu D, Wang Y, Zhuang Z, Xia H. J Neurosurg; 2016 Jan 10; 124(1):129-36. PubMed ID: 26274999 [Abstract] [Full Text] [Related]
33. STAT6 expression in glioblastoma promotes invasive growth. Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM. BMC Cancer; 2011 May 20; 11():184. PubMed ID: 21595984 [Abstract] [Full Text] [Related]
34. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma. Tian X, Zhang L, Sun L, Xue Y, Xie S. J Int Med Res; 2014 Jun 20; 42(3):651-8. PubMed ID: 24743871 [Abstract] [Full Text] [Related]
35. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Ruan J, Lou S, Dai Q, Mao D, Ji J, Sun X. Neuroreport; 2015 Jan 21; 26(2):66-73. PubMed ID: 25494473 [Abstract] [Full Text] [Related]
36. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas. Liu N, Wang Z, Cheng Y, Zhang P, Wang X, Yang H, Liu H, Zhang Y, Tu Y. Hum Pathol; 2016 Dec 21; 58():105-112. PubMed ID: 27574811 [Abstract] [Full Text] [Related]
37. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Shi Y, Chen C, Yu SZ, Liu Q, Rao J, Zhang HR, Xiao HL, Fu TW, Long H, He ZC, Zhou K, Yao XH, Cui YH, Zhang X, Ping YF, Bian XW. Clin Cancer Res; 2015 Sep 01; 21(17):4004-13. PubMed ID: 26023083 [Abstract] [Full Text] [Related]
38. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans. Hung KS, Howng SL. J Neurosurg; 2003 Nov 01; 99(5):886-92. PubMed ID: 14609169 [Abstract] [Full Text] [Related]
39. Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells. Aguilar-Morante D, Cortes-Canteli M, Sanz-Sancristobal M, Santos A, Perez-Castillo A. Neuroscience; 2011 Mar 10; 176():110-9. PubMed ID: 21185356 [Abstract] [Full Text] [Related]
40. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma. Ma J, Lang B, Wang X, Wang L, Dong Y, Hu H. J Clin Neurosci; 2014 Nov 10; 21(11):1885-90. PubMed ID: 25001988 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]